EnBio Holdings, Inc. Statistics
Want to see JP:6092 full AI Analyst Report?
EnBio Holdings, Inc. (6092) Stock Statistics & Valuation Metrics
Total Valuation
EnBio Holdings, Inc. has a market cap or net worth of JPY 6.04B. The enterprise value is JPY 12.54B.
- Market Cap
- JPY 6.04B
- Enterprise Value
- JPY 12.54B
Share Statistics
EnBio Holdings, Inc. has 8,175,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 8,175,200
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
EnBio Holdings, Inc.’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 2.17%.
- Return on Equity (ROE)
- 0.03
- Return on Assets (ROA)
- 0.01
- Return on Invested Capital (ROIC)
- 2.17%
- Return on Capital Employed (ROCE)
- 0.09
- Revenue Per Employee
- 111.77M
- Profits Per Employee
- 2.35M
- Employee Count
- 113
- Asset Turnover
- 0.55
- Inventory Turnover
- 2.01
Valuation Ratios
The current PE Ratio of EnBio Holdings, Inc. is 10.92. EnBio Holdings, Inc.’s PEG ratio is -0.01.
- PE Ratio
- 10.92
- PS Ratio
- 0.46
- PB Ratio
- 0.64
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- -0.01
Income Statement
In the last 12 months, EnBio Holdings, Inc. had revenue of 12.63B and earned 265.00M in profits. Earnings per share was 32.69.
- Revenue
- 12.63B
- Gross Profit
- 3.69B
- Operating Income
- 1.62B
- Pretax Income
- 915.00M
- Net Income
- 265.00M
- EBITDA
- 2.16B
- Earnings Per Share (EPS)
- 32.69
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
EnBio Holdings, Inc. pays an annual dividend of JPY 9.00, resulting in a dividend yield of 1.21%
- Dividend Per Share
- JPY 9.00
- Dividend Yield
- 1.21%
- Payout Ratio
- 12.53%
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 9.21%
Stock Price Statistics
- Beta
- 0.45
- 52-Week Price Change
- 28.87%
- 50-Day Moving Average
- 791.68
- 200-Day Moving Average
- 762.64
- Relative Strength Index (RSI)
- 42.63
- Average Volume (3m)
- 26.31K
Important Dates
EnBio Holdings, Inc. upcoming earnings date is Nov 18, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 14, 2026
- Next Earnings Date
- Nov 18, 2026
- Ex-Dividend Date
- Mar 30, 2026
Financial Position
EnBio Holdings, Inc. as a current ratio of 2.20, with Debt / Equity ratio of 115.19%
- Current Ratio
- 2.20
- Quick Ratio
- 1.34
- Debt to Market Cap
- 1.72
- Net Debt to EBITDA
- 3.06
- Interest Coverage Ratio
- 9.04
Taxes
In the past 12 months, EnBio Holdings, Inc. has paid 663.00M in taxes.
- Income Tax
- 663.00M
- Effective Tax Rate
- 0.72
Enterprise Valuation
EnBio Holdings, Inc. EV to EBITDA ratio is 5.05, with an EV/FCF ratio of 0.00.
- EV to Sales
- 0.97
- EV to EBITDA
- 5.05
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
EnBio Holdings, Inc. has JPY 4.04B in cash and marketable securities with JPY 10.65B in debt, giving a net cash position of -JPY 6.62B billion.
- Cash & Marketable Securities
- JPY 4.04B
- Total Debt
- JPY 10.65B
- Net Cash
- -JPY 6.62B
- Net Cash Per Share
- -JPY 809.40
- Tangible Book Value Per Share
- JPY 1,099.44
Margins
Gross margin is 30.81%, with operating margin of 14.92%, and net profit margin of 4.25%.
- Gross Margin
- 30.81%
- Operating Margin
- 14.92%
- Pretax Margin
- 10.15%
- Net Profit Margin
- 4.25%
- EBITDA Margin
- 19.13%
- EBIT Margin
- 14.92%
Analyst Forecast
The average price target for EnBio Holdings, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 28.93%
- EPS Growth Forecast
- 401.18%
Scores
- Smart Score
- ―
- AI Score
- 58
